National Health Investors (NYSE:NHI) issued an update on its FY 2018 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $3.73-3.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.75. National Health Investors also updated its FY18 guidance to $5.47-5.51 EPS.
NHI stock traded down $1.27 during midday trading on Tuesday, hitting $72.92. The company’s stock had a trading volume of 59,154 shares, compared to its average volume of 195,950. National Health Investors has a 12 month low of $62.71 and a 12 month high of $81.60. The company has a debt-to-equity ratio of 0.90, a current ratio of 15.56 and a quick ratio of 15.56. The company has a market capitalization of $3.08 billion, a price-to-earnings ratio of 13.68, a PEG ratio of 3.13 and a beta of 0.30.
National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, August 7th. The real estate investment trust reported $0.91 EPS for the quarter, missing analysts’ consensus estimates of $0.96 by ($0.05). The firm had revenue of $72.96 million for the quarter, compared to the consensus estimate of $73.80 million. National Health Investors had a net margin of 53.16% and a return on equity of 11.49%. Sell-side analysts anticipate that National Health Investors will post 5.51 EPS for the current fiscal year.
NHI has been the subject of a number of research reports. Zacks Investment Research upgraded National Health Investors from a hold rating to a buy rating and set a $83.00 target price for the company in a research report on Wednesday, July 25th. SunTrust Banks reiterated a hold rating and set a $79.00 target price on shares of National Health Investors in a research report on Wednesday, August 8th. They noted that the move was a valuation call. Stifel Nicolaus set a $83.00 target price on National Health Investors and gave the company a buy rating in a research report on Tuesday, August 7th. Cantor Fitzgerald increased their target price on National Health Investors from $75.00 to $80.00 and gave the company a neutral rating in a research report on Wednesday, August 8th. Finally, Wells Fargo & Co reiterated a hold rating on shares of National Health Investors in a research report on Tuesday, August 28th. One analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $75.22.
COPYRIGHT VIOLATION NOTICE: “National Health Investors (NHI) Updates FY 2018 Earnings Guidance” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/11/06/national-health-investors-nhi-updates-fy-2018-earnings-guidance.html.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Read More: Penny Stocks
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.